The largest database of trusted experimental protocols

Dako blocking reagent

Manufactured by Agilent Technologies
Sourced in United States

The DAKO blocking reagent is a laboratory product designed to reduce non-specific background staining in immunohistochemistry and in situ hybridization procedures. It is a ready-to-use solution that can be applied to tissue samples to block endogenous peroxidase and/or alkaline phosphatase activity, thereby improving the specificity of the targeted antigen or nucleic acid detection.

Automatically generated - may contain errors

8 protocols using dako blocking reagent

1

Immunodetection of Amyloid-Beta Species

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed, paraffin-embedded 8-μm human and mouse brain tissue sections were evaluated for immunoreactivity for total Aβ as well as for the presence of N- and C-terminal truncated species starting at amino acid residue 4 or ending at position 34 by light microscopy and immunofluorescence as indicated below. In all cases, sections were deparaffinized in xylene, rehydrated, and pretreated with 98% FA for 10 min as previously described [12 (link)]. Following quenching of endogenous peroxidase with Dako Blocking reagent (Dako North America, Carpinteria, CA), and blocking non-specific binding by 30 min incubation with 10% non-fat milk in PBS, sections were subjected to the different protocols indicated below.
+ Open protocol
+ Expand
2

Quantifying Kidney Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Kidneys from wildtype untreated C57BL/6 mice were dissected. Kidneys were fixed in RNase free 4% PFA overnight at 4°C and cryopreserved in 30% sucrose, cryo-sectioned (14 μm) and stored frozen at −20°C until use. The Affymetrix Quantigene View RNA (Affymetrix, Santa Clara, CA, USA) in situ hybridization system was used as per manufacturer's instructions. Sections were thawed and dried at 60°C prior to Protease Q (20 min, 40°C) treatment. Probes for CFH (accession No: NM_009888, Catalog No VB1-16095) and C3 (accession No: NM_009778, Catalog No VB1-13781), purchased from Affymetrix, were applied at 40°C for 4 h. A no probe control was run alongside each experiment. The probe was labeled using fast red dye (Affymetrix). After washing, slides were blocked in DAKO blocking reagent (Dako, Hamburg, Germany). Rabbit anti-laminin antibody was diluted in antibody diluting reagent (Dako) and incubated overnight at 4°C. Secondary antibody (1:200) diluted in antibody diluting reagent, was added after washing, and incubated for 3 h. DAPI nuclear counter stain was applied prior to mounting using Fluoromount and then imaged using Leica SP5.
+ Open protocol
+ Expand
3

Immunohistochemical Evaluation of LAG-3

Check if the same lab product or an alternative is used in the 5 most similar protocols
The immunohistochemical expression of LAG-3 was analyzed using a tissue microarray (KIN-2, AZUMAYA, Tokyo, Japan). Tissue microarrays consisted of paraffin-embedded tissue blocks constructed by extracting 3-mm cylindrical tissue cores, with appropriate histological findings. All blocks were sliced into Sect. (4 μm thick). After deparaffinization and heat-induced antigen retrieval using 1 mM ethylenediaminetetraacetic acid (pH 9.0), all sections were incubated with 3% hydrogen peroxidase for 10 min to quench the endogenous peroxidase activity. These sections were further incubated with DAKO Blocking Reagent (Protein Block Serum-Free Ready-to-use [Code X0909], DAKO North America Inc., California, USA) at room temperature for 20 min to block nonspecific antigens. LAG-3 antibody (Ab180187, clone EPR4392, diluted 1:1,500; Abcam) was applied as the primary antibody at 4 °C overnight. Secondary antibodies (HISTOFINE Simple Stain MAX-PO MULTI [NICHIREI Code 424,151], Nichirei Biosciences Inc., Tokyo, Japan) were applied at room temperature for 45 min. The antigen/antibody complex formation was performed in 3,3ʹ-diaminobenzidine tetrahydrochloride and hydrogen peroxidase substrate solution for 10 min and counterstained with hematoxylin for 5 s.
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of FoxO1 in Fetal Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was performed to assess FoxO1 protein expression in foetal thymus, lung and liver tissues. Five‐micrometre‐thick sections of FFPE blocks of foetal thymus, lung and liver tissues from autopsy cases were placed on silanized slides. For antigen retrieval, the sections were heated in citrate buffer (pH 6.0) for 30 min. using a microwave. Then, endogenous peroxidases were quenched with DAKO blocking reagent (Dako Corp., Carpinteria, CA, USA) for 15 min. The sections were incubated with a rabbit monoclonal anti‐FOXO1 antibody (1:100, Cell Signaling) and subsequently incubated with a biotinylated anti‐immunoglobulin and streptavidin‐peroxidase (DAKO LSAB kit, Dako Corp.). Rabbit mAb IgG isotype (1:100; Cell Signaling) was used as a negative control. Colour was developed using 3, 3‐diaminobenzidine tetrahydrochloride (DAB) for 3 min., and then, the sections were counterstained with haematoxylin for 1 min.
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of Regulated Cell Death

Check if the same lab product or an alternative is used in the 5 most similar protocols
For IHC, paraffin-embedded sections (3.5 μm) were dewaxed and rehydrated. Antigen retrieval was performed by incubation in sodium citrate buffer pH 6.0 at 65 °C overnight. After cooling, unspecific antigens were blocked with the DAKO blocking reagent (Dako, Glostrup, Denmark), followed by overnight incubation with the 1:250 diluted rabbit monoclonal antibody [EPR9514] against human p-MLKL (phospho S358; abcam, Cambridge, UK), human cleaved caspase 8 (NB100-56116; NOVUS Biologicals, Centennial, CO, USA) or RIPK3 (GTX107574; GeneTex, Irvine, CA, USA) at 4 °C. Sections were treated with 3% hydrogen peroxide before starting the staining with the Dako LSAB2 System-HRP kit (Dako, Glostrup, Denmark). In all samples a final staining of cell nuclei by Gill’s hematoxylin No 3 (Sigma-Aldrich) was performed. In case of cleaved CASP8 and p-MLKL, the percentage of positive cells was quantified by manual counting of the stained sections.
+ Open protocol
+ Expand
6

Quantification of Lung Metastasis via Ki67

Check if the same lab product or an alternative is used in the 5 most similar protocols
Upon sacrifice, lungs were inflated with a mixture of 1:1.5 OCT:PBS using a 26G needle. Inflated lungs were then embedded in OCT or FSC 22 Clear Frozen Section compound (cat. no. 3801480, Leica) and snap frozen and stored at −80 °C. Lungs were cryo-sectioned at 12 µm and then stained for expression of Ki67. Sections were allowed to thaw for 10 min, and then fixed in ice cold acetone (5 min). Endogenous peroxidases were quenched with 1% aqueous H2O2 in methanol for 15 min and then blocked in Dako Blocking reagent (cat. no. X0909, Dako) supplemented with 10% donkey serum (no. 017-000-121, Jackson ImmunoResearch) for 30 min. Ki67 (D3B5) Rabbit mAb (Mouse Preferred; IHC Formulated) (cat. no. 12202, Cell Signalling Technologies) was incubated overnight at 4 °C at a dilution of 1:200 in Dako antibody diluent with background reducing components (cat. no. S3022, Dako). After 3 washes in PBST, sections were incubated with LSAB2 Streptavidin-Peroxidase/SA-HRP kit (DAKO K0690) for 30 min, and then mounted using Permount (cat. no. # SP15-500, Fisher Scientific). Images were acquired on a Leica DM LB2 microscope and DFC 300 FX camera. ImageJ was used to determine the pixel area of the lung and also pixel area of metastatic nodules, from which the percentage metastasis area was calculated.
+ Open protocol
+ Expand
7

Immunofluorescence Staining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure immunofluorescence, 1 × 104 cells were seeded on 14‐mm coverslips in 8‐well plates. After treatment was completed the cells were washed with PBS, fixed in 4% paraformaldehyde‐PBS for 20 minutes at room temperature, and permeabilized in cold PBS with 0.2% Triton X‐100 for 10 minutes at room temperature. Blocking was carried out with Dako blocking reagent (#X0909; Agilent Technologies, Santa Clara, CA, USA) and 10% BSA for 40 minutes at room temperature. The slides were then incubated with primary antibody (α‐tubulin antibody, dilution 1:500) for 1 hour at room temperature and thereafter with anti‐rabbit Alexa 555 antibody (dilution 1:200). Coverslips were mounted on glass slides with DAPI containing Vectashield mounting medium (ProLong™ Gold Antifade Mountant with DAPI; Thermo Fisher Scientific, Waltham, MA, USA) and visualized by confocal microscopy.
+ Open protocol
+ Expand
8

Immunohistochemistry of EphA2 in PDX Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The immunohistochemistry (IHC) for EphA2 was performed manually according to standard procedure, on paraffin-embedded PDX tumor tissues. The antigen retrieval was performed with 15-min sub-boiling citrate buffer (pH = 6). Next, a peroxidase blockade was carried out with serum-free Dako blocking reagent (Agilent Technologies, Inc., Santa Clara, CA, USA). The primary antibody for EphA2 staining was D4A2 XP® Rabbit mAb #6997 (Cell Signaling Technologies, Danvers, MA, USA) diluted 1:200 and incubated overnight at 4 °C. Staining was obtained with Dako EnVision+ System- HRP Labelled Polymer Anti-Rabbit (Agilent Technologies, Inc., Santa Clara, CA, USA) followed by 3,3′-Diaminobenzidine as the standard chromogen and counter-staining with hematoxylin. Slide fixation was performed with mounting medium and observation under an optical microscope (Leica DM750, Leica Biosystems, Buccinasco, MI, Italy) equipped with a Leica ICC50W camera (Leica Biosystems).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!